Samalizumab Antibody
Samalizumab (ALXN 6000) is a humanized monoclonal antibody targeting the CD200 immune checkpoint protein. It is being investigated for hematological malignancies like myeloma and CLL, with research demonstrating its activity in both in vitro assays and in vivo preclinical models to modulate immune responses.
Product Specifications
Product Name Alternative
ALXN 6000, ALXN6000, ALXN-6000, Samalizumab
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
10.47 mg/mL
Purity
≥95% (May vary between batches)
Molecular Weight
~150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog